Sign in
Taking people in United StatesNo phase

Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation

Key facts

Who runs it
Weill Medical College of Cornell University
Where
Boston, Buffalo, Burlington, Camden, Chicago, Columbia, Danville, Edison, Galveston, Houston, Jackson, Los Angeles, Louisville, Madison, Miami, Morgantown, Nashville, Neptune City, New Brunswick, New Haven, New York, Omaha, Park Ridge, Philadelphia, Phoenix, Portland, Sacramento, Salt Lake City, Seattle, Sioux Falls, St Louis, Summit, Tampa, Temple, Tucson, and Walnut Creek, United StatesSee the 44 sites
Trial code
Status
Recruiting
People taking part
300 people, planned
Started
10 Jul 2026
Expected to end
31 Jul 2030
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Endoscopic ICH evacuation
  • Standard Medical Treatment
Record updated
15 September 2026

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 25 criteriaShow less

Who can take part

  • Age ≥ 18 and ≤ 80 years
  • Non-traumatic, spontaneous, supratentorial, non-thalamic, BGH of volume ≥ 20 mL, as determined by the treating physician using ABC/2 method
  • NIHSS ≥ 6 at presentation
  • CTA or MRA is performed and does not show an underlying vascular lesion
  • Pre-ICH mRS 0-2
  • Informed consent from patient or LAR to participate in the trial, wherein patient/LAR's stated wishes are to pursue lifesaving therapies as opposed to early withdrawal of care (explicitly explained as <7 days following ictus)
  • The treating physician anticipates that surgery can be initiated <120 min from randomization
  • Randomization within 16 hours from LKW and within 2 hours of arrival to the randomizing center

Who cannot take part

  • Concurrent use of direct oral anticoagulants or low molecular weight heparin at ICH onset
  • Current participation in another interventional (drug or device) trial
  • Infratentorial or thalamic hemorrhage
  • Evidence of active infection indicated by fever ≥100.7 °F and/or open draining wound at the time of enrollment
  • Any comorbid disease or condition expected to compromise survival or ability to complete follow-up assessments through 365 days
  • Intraventricular extension of the hemorrhage is visually estimated to involve > 50% of either of the lateral ventricles
  • History of severe dementia
  • Coagulopathy defined as international normalized ratio (INR) > 1.4
  • Elevated activated Partial Thromboplastin Time (aPTT) > 40 s
  • Platelet count <100 x 103 cells/mm3, or known platelet dysfunction (reversal of coagulopathy is not allowed)
  • Suspected secondary cause for the ICH, such as an underlying vascular malformation (cavernous malformation, arteriovenous malformation, etc.), aneurysm, neoplasm, hemorrhagic transformation of an underlying ischemic infarct; or venous infarct
  • Midbrain extension/involvement
  • Known hereditary or acquired hemorrhagic diathesis or coagulation factor deficiency
  • GCS score <7 at presentation
  • Pregnancy (women of childbearing potential must have a negative pregnancy test to participate)
  • Based on investigator's judgment, the patient does not have the necessary mental capacity to participate or is unwilling to comply with the protocol follow-up schedule
  • Pre-existing Do Not Resuscitate (DNR)/Do Not Intubate (DNI) status

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Where in United States

  • Beth Israel Deaconess Medical CenterBoston, United StatesContact: Mark RotondoNot yet recruiting
  • Buffalo General Medical CenterBuffalo, United StatesContact: Michaela LaskowskiNot yet recruiting
  • Lahey Hospital & Medical CenterBurlington, United StatesContact: Madison LieschingTaking people
  • Cooper University HospitalCamden, United StatesContact: Thuy Van CaoNot yet recruiting
  • Northwestern Memorial HospitalChicago, United StatesContact: Ashkan ZarrienehNot yet recruiting
  • University of Illinois HospitalChicago, United StatesContact: Luzy RosalesNot yet recruiting
  • University of Missouri Health CareColumbia, United StatesContact: Brooke HoffmanNot yet recruiting
  • Geisinger Medical CenterDanville, United StatesContact: Chelsie DerrNot yet recruiting
  • JFK Medical CenterEdison, United StatesContact: Alexandra BurbeloNot yet recruiting
  • University of Texas Medical BranchGalveston, United StatesContact: Jennifer CornwellNot yet recruiting
  • Houston Methodist HospitalHouston, United StatesContact: Amber BehneNot yet recruiting
  • Memorial Hermann Texas Medical CenterHouston, United StatesContact: Atzhiry PazNot yet recruiting
  • University of Mississippi Medical CenterJackson, United StatesContact: Thomas HudsonNot yet recruiting
  • Cedars-Sinai Medical CenterLos Angeles, United StatesContact: Sun Ming NaTaking people
  • Keck Hospital of USCLos Angeles, United StatesContact: Clare BinleyNot yet recruiting
  • Ronald Reagan UCLA Medical CenterLos Angeles, United StatesContact: Chevelle SleafordTaking people
  • University of Louisville HospitalLouisville, United StatesContact: Ann JerdeNot yet recruiting
  • University of Wisconsin - University HospitalMadison, United StatesContact: Sima SayyahmelliNot yet recruiting
  • Jackson Memorial HospitalMiami, United StatesContact: Jayro ToledoNot yet recruiting
  • J.W. Ruby Memorial HospitalMorgantown, United StatesContact: Jay ShermanNot yet recruiting
  • Vanderbilt University HospitalNashville, United StatesContact: Anna BicanNot yet recruiting
  • Jersey Shore University Medical CenterNeptune City, United StatesContact: Abimbola CokerNot yet recruiting
  • Robert Wood Johnson University HospitalNew Brunswick, United StatesContact: Christine YohnTaking people
  • Yale New Haven HospitalNew Haven, United StatesContact: Kristin DeFrancescoTaking people
  • NYP/Weill Cornell Medical CenterNew York, United StatesContact: Jackson HagenTaking people
  • NYU Langone HealthNew York, United StatesContact: Michelle SclafaniTaking people
  • The Mount Sinai HospitalNew York, United StatesContact: Emily SvendsenTaking people
  • University of Nebraska Medical CenterOmaha, United StatesContact: Jill SkorupaNot yet recruiting
  • Advocate Lutheran General HospitalPark Ridge, United StatesContact: Miharsh PatelNot yet recruiting
  • Hospital of the University of PennsylvaniaPhiladelphia, United StatesContact: Ashlynn SolomonNot yet recruiting
  • Banner-University Medical Center PhoenixPhoenix, United StatesContact: Hira IsmailNot yet recruiting
  • Mayo ClinicPhoenix, United StatesContact: Debbie RyanNot yet recruiting
  • Oregon Health & Science University HospitalPortland, United StatesContact: Megan PattleNot yet recruiting
  • UC Davis Medical CenterSacramento, United StatesContact: Savina NguyenNot yet recruiting
  • University of Utah HealthcareSalt Lake City, United StatesContact: Andrew GrandmangeNot yet recruiting
  • Harborview Medical CenterSeattle, United StatesContact: Lauren KleinNot yet recruiting
  • Avera McKennan Hospital & University Health CenterSioux Falls, United StatesContact: Cassidy KaiserNot yet recruiting
  • SSM Health St. Louis University HospitalSt Louis, United StatesContact: Edwin AkomaningNot yet recruiting
  • Washington University (Barnes-Jewish Hospital)St Louis, United StatesContact: Porche BraunNot yet recruiting
  • Overlook Medical CenterSummit, United StatesContact: Juliana ColecchiaNot yet recruiting
  • Tampa General HospitalTampa, United StatesContact: Sai Priyanka AnnadasuTaking people
  • Baylor Scott & White Medical CenterTemple, United StatesContact: Michelle VanecekTaking people
  • Banner-University Medical Center Tucson CampusTucson, United StatesContact: Kylie LewNot yet recruiting
  • John Muir Medical Center - Walnut Creek CampusWalnut Creek, United StatesContact: Melanie AaronNot yet recruiting

About the trial

What the trial wants to find out

MINUTE is a prospective, multi-center, randomized, controlled, blinded assessor, adaptive enrichment design, clinical trial. Eligible patients with spontaneous BGH ≥20 mL will be randomized 1:1 to either minimally invasive endoscopic SCUBA evacuation plus standard medical management or standard medical management alone; the time of randomization will be used to classify participants in one of two cohorts: 1) those randomized <8 hours from onset, and 2) those randomized 8-16 hours from onset. Randomization is targeted to occur within 120 min of arrival to the randomizing center's Emergency Department (ED), and initiation of surgery is targeted to occur within 120 min of randomization. Participants will be followed at 30, 90, 180, and 365 days to assess for adverse events (AEs) and utility-weighted modified Rankin Scale (UW-mRS).

The 2 groups in the trial

  • Endoscopic ICH evacuation (SCUBA) and Standard Medical TreatmentTreatment being tested

    Participants will be treated with SCUBA and Standard Medical Treatment

    Treatment: Endoscopic ICH evacuation and Standard Medical Treatment

  • Standard Medical TreatmentPlacebo, for comparison

    Participants will be treated with Standard Medical Treatment

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation (MINUTE) Trial
Fit questions
Built from NCT07260916, who can take part
Record updated
15 September 2026